Today: 9 April 2026
Prudential plc share price today: buyback update hits after Thursday slide
6 February 2026
2 mins read

Prudential plc share price today: buyback update hits after Thursday slide

London, February 6, 2026, 09:23 GMT — Regular session

  • Prudential shares were down 0.1% at 1,174 pence in early London trade
  • Company disclosed it bought back 494,445 shares on Feb. 5 under its 2026 programme
  • Stock fell 3.3% on Thursday after setting a fresh 52-week high a day earlier

Prudential plc (PRU.L) shares were down 0.1% at 1,174 pence by 09:23 GMT on Friday after the insurer reported another round of share repurchases. The stock has traded between 1,153.5p and 1,174p so far in the session, and Prudential said it bought back 494,445 shares on Thursday. https://www.investing.com/equities/prudent… https://www.investegate.co.uk/announcement…

The daily buyback notices are routine, but they matter this week because the stock has been swinging after a run to a fresh high. A buyback means a company uses cash to buy its own shares, often to cancel them and shrink the share count.

Prudential fell 3.3% on Thursday, underperforming a weak FTSE 100 session, after hitting £12.38 a day earlier, MarketWatch data showed. Turnover ran above the recent average, a sign some short-term money was heading for the exit. https://www.marketwatch.com/data-news/prud…

In Friday’s filing, Prudential said it paid between £11.6850 and £12.1350 per share, with an average price of £11.8709. It said it plans to cancel the stock, taking shares in issue and voting rights to 2,540,805,795. http://www.rns-pdf.londonstockexchange.com…

The repurchases are part of a $1.2 billion programme launched in January and set to run through 2026. Chief Executive Anil Wadhwani said at the time: “I am pleased with the progress we are making in executing our strategy.” https://www.prudentialplc.com/en/newsroom/…

For equity investors, the buyback is one of the few visible levers between now and results, and it can help steady a stock when the fundamentals are quiet. Prudential earns most of its money in life and health insurance and asset management across Asia and Africa, and it is not affiliated with U.S. insurer Prudential Financial. https://www.reuters.com/company/prudential…

Friday’s tape underlined how quickly sentiment can shift. The share price is still some way below Wednesday’s peak, yet only a shade off Thursday’s close.

But the buyback is not a floor. Prudential has said the pace and timing of capital returns depend on market conditions, and the stock can still drift if risk appetite fades or Asia-facing insurers fall out of favour. https://www.investing.com/news/stock-marke…

The next question for traders is whether buyers return around the morning low and keep the shares in range into the weekend. A sharper rebound would hint Thursday’s drop was more profit-taking than a new view on the business.

Next up is the group’s full-year results, listed on its financial calendar for March 19 in Hong Kong, which is March 18 in the UK. Investors will be looking for updates on capital generation, dividends and the pace of buybacks, along with any read-through on sales momentum in key Asian markets. https://www.prudentialplc.com/en/investors…

Stock Market Today

  • Ultragenyx Pharmaceutical Shares Surge 8.1% Weekly Amid Valuation Debate
    April 9, 2026, 2:08 AM EDT. Ultragenyx Pharmaceutical (RARE) shares rose 8.1% last week to $23.15 amid mixed performance, down 1.9% year-to-date and 31.7% over 12 months. The biotech specializes in rare disease treatments, a sector sensitive to clinical trial and regulatory updates. Despite recent gains, the company's long-term returns remain negative. A discounted cash flow (DCF) analysis values Ultragenyx at about $257.43 per share, suggesting it is 91% undervalued based on future free cash flow projections turning positive by 2026. However, actual cash flow remains negative at $501.5 million last year. Investors must weigh DCF optimism against market risks and sector volatility. Ultragenyx scores 4 out of 6 in valuation, indicating some appeal but highlighting areas needing scrutiny.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 09.04.2026

9 April 2026
LIVEMarkets rolling coverageStarted: April 9, 2026, 12:00 AM EDTUpdated: April 9, 2026, 2:11 AM EDT Ultragenyx Pharmaceutical Shares Surge 8.1% Weekly Amid Valuation Debate April 9, 2026, 2:08 AM EDT. Ultragenyx Pharmaceutical (RARE) shares rose 8.1% last week to $23.15 amid mixed performance, down 1.9% year-to-date and 31.7% over 12 months. The biotech specializes in rare disease treatments, a sector sensitive to clinical trial and regulatory updates. Despite recent gains, the company's long-term returns remain negative. A discounted cash flow (DCF) analysis values Ultragenyx at about $257.43 per share, suggesting it is 91% undervalued based on future free cash flow
Why IREN Stock Is Back in Focus as AI Ambitions Meet Funding Fears

Why IREN Stock Is Back in Focus as AI Ambitions Meet Funding Fears

8 April 2026
IREN shares rose 1.8% to $35.74 Wednesday as investors assessed its $6 billion share program and shift from bitcoin mining to AI cloud services. The company’s revenue fell to $184.7 million last quarter, with a net loss of $155.4 million. IREN recently announced a five-year, $9.7 billion AI cloud deal with Microsoft. Options trading volume hit 103,000 contracts Tuesday, with sentiment described as mixed.
Amazon Stock Could Jump 50% as Wall Street Reconsiders Its $200 Billion AI Bet

Amazon Stock Could Jump 50% as Wall Street Reconsiders Its $200 Billion AI Bet

8 April 2026
Amazon closed at $213.77 Tuesday, with BNP Paribas maintaining a $320 price target, citing strong AI demand despite Amazon’s planned $200 billion capex for 2026. The company’s February forecast of higher spending sent shares down 11.5% after hours, even as AWS revenue rose 24% to $35.6 billion in the December quarter. Alphabet and Microsoft are also ramping up AI infrastructure spending.
Sensex Soars 2,946 Points, Nifty Near 24,000 After Iran Ceasefire and RBI Pause

Sensex Soars 2,946 Points, Nifty Near 24,000 After Iran Ceasefire and RBI Pause

8 April 2026
The Sensex surged 2,946 points to 77,562.90 on Wednesday, its best day in five years, as a U.S.-Iran ceasefire and steady RBI rates pushed Indian markets higher. Brent crude fell 14.4% to $93.49 a barrel, easing pressure on the rupee, which rose 0.5% to 92.58 per dollar. All 16 major sectors gained, led by financials and auto stocks. The RBI kept its repo rate at 5.25% and forecast slower growth ahead.
Netflix Stock Draws Fresh Institutional Buying Ahead of Earnings After Goldman Upgrade

Netflix Stock Draws Fresh Institutional Buying Ahead of Earnings After Goldman Upgrade

8 April 2026
Stock Yards Bank & Trust Co. increased its Netflix stake by 1,141.9% to 29,074 shares in Q4, while Ethos Capital Management disclosed a new 19,610-share position worth $1.84 million. The moves come ahead of Netflix’s April 16 earnings report and follow a Goldman Sachs upgrade to Buy with a $120 target. Insiders Reed Hastings and Greg Peters sold shares earlier this year under preset trading plans. Netflix last traded at $98.82.
Beazley Plc stock price edges up as Zurich bid keeps traders glued to Feb 16 deadline
Previous Story

Beazley Plc stock price edges up as Zurich bid keeps traders glued to Feb 16 deadline

Diageo share price slips as traders eye Feb 25 results and CEO’s next move
Next Story

Diageo share price slips as traders eye Feb 25 results and CEO’s next move

Go toTop